切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2015, Vol. 04 ›› Issue (04) : 358 -360. doi: 10.3877/cma.j.issn.2095-3224.2015.04.01

所属专题: 文献

述评

结直肠癌肺转移的外科治疗
杨昆1, 赵峻1, 赫捷1,()   
  1. 1. 100021 北京,中国医学科学院肿瘤医院胸外科
  • 收稿日期:2015-06-05 出版日期:2015-08-25
  • 通信作者: 赫捷
  • 基金资助:
    国际科技合作与交流专项(2015DFA31090)

Surgical treatment for the lung metastasis of colorectal cancer

Kun YANG1, Jun ZHAO1, Jie HE1,()   

  1. 1. Department of Thoracic Surgery, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing 100021, China
  • Received:2015-06-05 Published:2015-08-25
  • Corresponding author: Jie HE
  • About author:
    Corresponding author: HEJie Email:
引用本文:

杨昆, 赵峻, 赫捷. 结直肠癌肺转移的外科治疗[J/OL]. 中华结直肠疾病电子杂志, 2015, 04(04): 358-360.

Kun YANG, Jun ZHAO, Jie HE. Surgical treatment for the lung metastasis of colorectal cancer[J/OL]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2015, 04(04): 358-360.

结直肠癌是我国的常见恶性肿瘤,发病率居第三位。约20%的结直肠癌初诊时就伴有远处转移,其中肺是最常见的转移部位之一。大量文献表明,对于结直肠癌伴有局限性肺转移的患者手术切除转移病灶,术后的5年生存率为21%~64%。存在其他可切除转移灶并不是手术禁忌。对于手术耐受良好的肺部转移瘤术后复发的患者,再次手术仍可生存获益。距离病灶0.5cm~1.0cm楔形切除是肺外周型病灶的经典术式。对于结直肠癌肺转移瘤手术胸腔淋巴结清扫仍有不同观点。目前公认的结直肠癌肺转移预后不良的因素包括:多发肺转移瘤、癌胚抗原水平升高、胸内淋巴结转移、无瘤间期较短。基于精准医学的个体化治疗将是未来进一步改善预后的关键。

Colorectal cancer is the third most common malignancy in China.About 20% patients have distant metastasis at the time of diagnosis.The lung is one of the most frequently involved organs.Massive documents indicate that for patients with limited lung metastasis, 5 year survival following surgical resection would be 21%-64%, simultaneous resectable other metastatic lesion should not be the contra-indication for surgery.Patients with good tolerance of surgery would still benefit from resection of the recurrent tumor after initial resection of lung metastatic tumor.Wedge resection with resection margin of 0.5cm~1.0cm is the standard of care for peripheral metastatic tumors.There is much controversy on the dissection of the chest lymph nodes.Multiple lung metastatic tumor, elevated CEA level, lymph node metastasis in the chest, and the short tumor free interval are factors indicating poor prognosis.For patients with lung metastasis of colorectal cancer, individualized therapy on the basis of precision medicine is the key point to increase the survival rate in the future.

[1]
American Cancer Society.Cancer Facts & Figures 2010.Atlanta: American Cancer Society, 2010: 12-13.
[2]
万德森.我国结直肠癌的流行趋势及对策.中华肿瘤杂志,2011,33: 481-483.
[3]
卫生部医改司,结直肠癌诊疗规范专家工作组.结直肠癌诊疗规范(2010年版).中华胃肠外科杂志,2010,13: 865-875.
[4]
梁建伟,周志祥,刘骞,等.可切除结直肠癌肺转移的预后因素分析.中华肿瘤杂志,2010,32(9): 694-697.
[5]
McCormack PM, Burt ME, Bains MS, et al.Lung resection for colorectal metastases, 10-years results.ArcbSurg, 1992, 127(12): 1403-1406.
[6]
Goya T, Miyazawa N, Kondo H, et al.Surgical resection of pulmonary metastases from colorectal cancer, 10-year follow up.Cancer, 1989, 64(7): 1418-1421.
[7]
David ISternberg, Joshua RSonett.Surgical therapy of lung metastases.Semin Oncol, 2007, 34: 186-196.
[8]
赫捷.结直肠癌肺转移的外科治疗原则.中华普外科手术学杂志,2010,4: 21-24.
[9]
梁立,吕世旭,许剑民,等.结直肠癌肺转移外科手术疗效评价.中华胃肠外科杂志,2010,15: 333-336.
[10]
Warwinck R, Page R. Resection of pulmonary metastases from colorectal carcinoma.Eur J SurgOncol, 2007, 33(Suppl 2): S59-S63.
[11]
Pfannschmidt J, Muley T, Hoffmann H, et al.Prognostic factors and survival after complete resection of pulmonary metastases from colorectal carcinoma: experiences in 167 patients.J Thorac Cardiovasc Surg, 2003, 126: 732-739.
[12]
Ercan S, Nichols FC, Trastek VF, et al.Prognostic significance of lymph node metastasis found during pulmonary metastasectomy for extrapulmonary carcinoma.Ann Thorac Surg, 2004, 77: 1786-1791.
[13]
Pfannschmidt J, Klode J, Muley T. Nodal involvement at the time of pulmonary metastasectomy.Experience in 245 patients.Ann ThoracSurg, 2006, 81: 448-454.
[14]
Jaklitsch MT, Mery CM, Lukanich JM, et al.Sequential thoracic metastasectomy prolongs survival by re-establishing local control within the chest.J Thorac Cardiovasc Surg, 2001, 121: 657-667.
[15]
Ogata Y, Matono K, Hayashi A, et al.Repeat pulmonary resection for isolated recurrent lung metastases yields results comparable to those after first pulmonary resection in colorectal cancer.World J Surg, 2005, 29: 363-368.
[16]
Limmer S, Oevermann E, Killaitis C, et al.Sequential surgical resection of hepatic and pulmonary metastases from colorectal cancer.Langenbecks Arch Surg, 2010, 395(8): 1129-1138.
[17]
Inoue M, Ohta M, Iuchi K, et al.Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma.Ann Thorac Surg, 2004, 78: 238-244.
[18]
Yedibela S, Klein P, Feuchter K, et al.Surgical management of pulmonary metastases from colorectal cancer in 153 patients.Ann Surg Oncol, 2006, 13: 1538-1544.
[19]
Pfannschmidt J, Dienemann H, Hoffmann H. Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series.Ann Thorac Surg, 2007, 84: 324-338.
[20]
Rena O, Casadio C, Viano F, et al.Pulmonary resection for metastases from colorectal cancer: factors influencing prognosis.Twenty-year experience.Eur J CardiothoracSurg, 2002, 21: 906-912.
[21]
赵亮,杨龙海,张白华,等.肺转移瘤的外科治疗临床分析.中华医学杂志,2015,95(9): 676-680.
[22]
郝云鹤,姜争,苗大壮,等.结直肠癌肺转移的治疗与预后因素分析.中华外科杂志,2012,50(3): 211-214.
[1] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[2] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[3] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[4] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[5] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[6] 孙莲, 马红萍, 吴文英. 局部进展期甲状腺癌患者外科处理[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 112-114.
[7] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[8] 顾雯, 凌守鑫, 唐海利, 甘雪梅. 两种不同手术入路在甲状腺乳头状癌患者开放性根治性术中的应用比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 687-690.
[9] 付成旺, 杨大刚, 王榕, 李福堂. 营养与炎症指标在可切除胰腺癌中的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 704-708.
[10] 李伟, 宋子健, 赖衍成, 周睿, 吴涵, 邓龙昕, 陈锐. 人工智能应用于前列腺癌患者预后预测的研究现状及展望[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 541-546.
[11] 刘卓, 张宗明, 张翀, 刘立民, 赵月, 齐晖. 腹腔镜手术治疗高龄急性梗阻性化脓性胆管炎患者的安全性与术式选择[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 795-800.
[12] 陈宗杰, 胡添松. 肝外伤破裂患者治疗后胆漏发生影响因素分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 836-840.
[13] 关小玲, 周文营, 陈洪平. PTAAR在乙肝相关慢加急性肝衰竭患者短期预后中的预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 841-845.
[14] 张润锦, 阳盼, 林燕斯, 刘尊龙, 刘建平, 金小岩. EB病毒相关胆管癌伴多发转移一例及国内文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 865-869.
[15] 王景明, 王磊, 许小多, 邢文强, 张兆岩, 黄伟敏. 腰椎椎旁肌的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 846-852.
阅读次数
全文


摘要